Impact of travel on international spread of antimicrobial resistance

International Journal of Antimicrobial Agents

Volumn 21, Issue 2, 2003, Pages 135-142

  Memish, Ziad A ^a   Venkatesh, S ^a   Shibl, Atef M ^b  

^a KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antimicrobial resistance; Clonal spread; Surveillance; Travel

Indexed keywords

ANTIBIOTIC AGENT; CHLOROQUINE; FOOD ADDITIVE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIAL TRANSMISSION; CAMPYLOBACTER JEJUNI; DATA BASE; DRUG USE; ENTEROCOCCUS FAECIUM; ESCHERICHIA COLI; GENE TRANSFER; GENETIC ENGINEERING; HEALTH CARE POLICY; HEALTH EDUCATION; HUMAN; INFECTION; INFECTION CONTROL; MALARIA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIGRATION; MOLECULAR BIOLOGY; MONITORING; MULTIDRUG RESISTANCE; NEISSERIA GONORRHOEAE; NONHUMAN; PLANT; PLASMODIUM FALCIPARUM; PRESCRIPTION; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SALMONELLA ENTERICA; SALMONELLA ENTERITIDIS; SALMONELLA TYPHIMURIUM; STREPTOCOCCUS PNEUMONIAE; TRAVEL; TUBERCULOSIS; VETERINARY MEDICINE; ZOONOSIS;

EID: 0037294007     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(02)00363-1     Document Type: Article

References (55)

1. World Health Organization. Removing obstacles to healthy development: report on infectious diseases, WHO, Geneva; 1999.
2. Institute of Medicine. Forum on emerging infections. antimicrobial resistance: issues and options. Washington, DC; 1998.
3. American Society of Microbiology. Report of the ASM Task Force on Antibiotic Resistance. Washington, DC; 1994.
4. House of Lords, UK. Resistance to antibiotics and other antimicrobial agents. Seventh Report of the House of Lords' Select Committee on Science and Technology; 1997-98. London, UK: The Stationary Office; 1998.
5. Williams R. Resistance as a worldwide problem. Lewis K., et al. Bacterial resistance to antimicrobials. 2001;Marcel Dekker Inc.
6. Calva J.J., Sifuentes-Osornio J., Ceron C. Antimicrobial resistance in fecal flora: longitudinal community-based surveillance of children from urban Mexico. Antimicrob. Agents Chemother. 40:1996;1699-1702.
7. Zenilman J.M. Emerging drug resistance and vaccination for typhoid fever. JAMA. 279:1998;580.
8. Glynn M.K., Bopp C., Dewitt W., Dabney P., Mokhtar M., Angulo F.J. Emergence of multidrug-resistant Salmonella enterica serotype typhimurium DT104 infections in the United States. N. Engl. J. Med. 338:(19):1998;1333-1338.
9. Juven T., Mertsola J., Waris M., Leinonen M., Meurman O., Roivainen M., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr. Infect. Dis. J. 19:2000;293-298.
10. World Health Organization. WHO report on infectious diseases 2000. Overcoming antimicrobial resistance. Geneva; 2000. WHO/CDS/2000.2.
11. Quednau M., Ahrne S., Molin G. Genomic relationship between Enterococcus faecium strains from different sources and with different antibiotic resistance profiles evaluated by restriction endonuclear analysis of total chromosomal DNA using EcoRI and PvuII. Appl. Environ. Microbiol. 65:(4):1999;1777-1780.
12. Tapsall J. Antimicrobial resistance in Neisseria gonorrhoeae. Geneva, World Health Organization; 2001. WHO/CDS/CSR/DRS/2001.3.
13. Murrary B.E., Mathewson J.J., DuPont H.I., et al. Emergence of resistant fecal E. coli in travellers not taking prophylactic antimicrobial agents. Antimicrob. Agents Chemother. 34:1990;515-518.
14. Kenyon T.A., Driver C., Haas E., Valway S.E., Moser K.S., Onorato I.M. Immigration and tuberculosis among children on the United States - Mexico border, County of San Diego, California. Pediatrics. 104:(1):1999;e8.
15. Wenzel P. Airline travel and infection. NEJM. 334:1996;981-982.
16. Musser J.M., Kapur V. Clonal analysis of methicillin-resistant Staphylococcus aureus strains from intercontinental sources: association of the mec gene with divergent phylogenetic changes lineages implies dissemination by horizontal transfer and recombination. J. Clin. Microbiol. 30:1992;2058-2063.
17. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no. 2. Prevalence and trends. The WHO/IUATLD global project on antituberculosis drug resistance surveillance. Geneva; 2000. WHO/CDS/TB/2000.278.
18. White N.J. Drug resistance in malaria. Br. Med. Bull. 54:1998;703-715.
19. Swanstrom R., Erona J. Human immunodeficiency virus type-1 protease inhibitors: therapeutic successes and failures, suppression and resistance. Pharmacol. Ther. 86:2000;145-170.
20. Vella S., Palmisano L. Antiretroviral therapy: state of the HAART. Antiviral Res. 45:2000;1-7.
21. Djimdé A., Dainbo O.K., Crtese J.F., Kayentao O.K., et al. A molecular marker for chloroquine-resistant falciparum malaria. N. Engl. J. Med. 344:(4):2001;257-263.
22. World Health Organization. The medical impact of the use of antimicrobials in food animals. Report and proceedings of a WHO meeting. Berlin, Germany; 13-17 October 1997. WHO/EMC/ZOO/97.4.
23. The use of drugs in food animals: benefits and risks. 1999;National Academy Press, Washington, DC.
24. Food and Drug Administration. Antibacterial drugs in animal feeds. Human health safety criteria guideline 18; 1998.
25. General Accounting Office. The agricultural use of antibiotics and its implications for human health; 1999.
26. National Research Council. The use of drugs in food animals: benefits and risks; 1999.
27. Advisory Committee on the Microbiological Safety of Food, UK. Report on microbial antibiotic resistance in relation to food safety. London, UK: The Stationery Office; 1999.
28. Joint Expert Advisory Committee on Antibiotic Resistance (JETACAR). The use of antibiotics in food-producing animals: antibiotic resistant bacteria in animals and humans. Australia: Commonwealth Department of Health and Aged Care, Commonwealth Department of Agriculture, Fisheries and Forestry; 1999.
29. World Health Organization. WHO global principles for the containment of antimicrobial resistance in animals intended for food. Report of a WHO Consultation; 5-9 June 2000. Geneva, Switzerland. WHO/CDS/CSR/APH/2000.4.
30. European Commission, Scientific Steering Committee. Opinion of the Scientific Steering Committee on antimicrobial resistance. Brussels: European Commission, Directorate-General DGXXIV; 1999.
31. McKeller Q.A. Antimicrobial resistance: a veterinary perspective. Antimicrobials are important for animal welfare but need to be used prudently. BMJ. 317:1998;610-611.
32. Alliance for the Prudent Use of Antibiotics. Antibiotic resistance: synthesis of recommendations by expert policy groups. Geneva, World Health Organization; 2001. WHO/CDS/CSR/DRS/2001.10.
33. Dahl K.H., Simonsen G.S., Olsvik O., et al. Heterogenicity in the vanB gene cluster of genomically diverse clinical strains of VRE. Antimicrob. Agents Chemother. 43:1999;1105-1110.
34. van den Bogaard A.E., Bruinsma N., Stobberingh E.E. The effect of banning avoparcin on VRE carriage in The Netherlands. J. Antimicrob. Chemother. 46:2000;146-147.
35. Danish Integrated Resistance Monitoring and Research Programme. DANMAP 99 - Consumption of antimicrobial agents and occurrence of antimicrobial resistance in bacteria from food animals, food and humans in Denmark. Statens Serum Institut, Danish Veterinary and Food Administration, Danish Medicines Agency and Danish Veterinary Laboratory; July 2000.
36. Bager F., Aarestrup F.M., Madson M., Wegener H.C.l. Glycopeptide resistance in Enterococcus faecium from broilers and pigs following discontinued use of avoparcin. Microb. Drug Resist. 5:1999;53-56.
37. Klare I., Badstubner D., Konstabel C., Bohme G., Claus H., White W. Decreased incidence of VanA-type vancomycin-resistant enterococci isolated from poultry meat and from fecal samples of humans in the community after discontinuation of avoparcin usage in animal husbandry. Microb. Drug Resist. 5:1999;45-52.
38. American Society for Microbiology. Report of the ASM Taskforce on Antibiotic Resistance. Proceedings of the American Society for Microbiology; 1994 Jul 6; Washington, DC. Washington DC: Office of Public Affairs, American Society for Microbiology; 1995.
39. World Health Organization. Use of quinolones in food animals and potential impact on human health. Report and proceedings of a WHO meeting, Geneva, Switzerland, 2-5 June 1998. Geneva; 1998. WHO/EMC/ZDI/98.12.
40. Molbak K., Baggesen D.L., Aarestrup F.M., Ebbesen J.M., Engberg J. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype typhimurium DT104. N. Engl. J. Med. 341:1999;1420-1425.
41. Endtz H.P., Rujisg J., Van Klingenen B., Jansen W.H., Vander Reyden T., Mouton R.P. Quinolone resistance in campylobacter isolated from man and poultry following the introduction of fluoroquinolones in veterinary medicine. J. Antimicrob. Chemother. 27:1991;199-208.
42. Alliance for the Prudent Use of Antibiotics. Antibiotic resistance: synthesis of recommendations by expert policy groups. Geneva, World Health Organization; 2001. WHO/CDS/CSR/DRS/2001.10.
43. Report of the Joint Committee on the use of antibiotics in animal husbandry and veterinary medicine. Chairman Professor M. Swann, Cmnd 4190. The Stationary Office, London UK; 1969.
44. World Health Organization. WHO global principles for the containment of antimicrobial resistance in animals intended for food; 2000. WHO/CDS/CSR/APH/2000.4. Available from: http://www.who.int/emc/diseases/zoo/who_global_principles.html.
45. Royal Society of Medicine. Resistant Organisms: Global impact on continuum of care. Proceedings of a conference sponsored by 3M Health Care and Regent Medical, London, September 27; 1996.
46. Office of Technology Assessment, US Congress. Impacts of antibiotic-resistant bacteria. Washington, DC: US Government Printing Office; 1995.
47. Chadwick D, Goode J, editors. Antibiotic resistance: origins, evolution, selection and spread. Proceedings from a Ciba Foundation Symposium, London July 16-18, 1996.Wiley; 1997.
48. World Health Organization. Proceedings of the WHO Scientific Working Group on Monitoring and Management of Bacterial Resistance to Antimicrobial Agents; 1994 November 29-December 2; Geneva, Switzerland. Geneva Switzerland: World Health Organization; 1995.
49. World Health Assembly Resolution 48.13. Communicable disease prevention and control: New emerging and re-emerging infectious diseases. Geneva, Switzerland; May 12, 1995.
50. World Health Organization. Global strategy for the containment of antimicrobial resistance. Geneva, Switzerland: World Health Organization; 2001. WHO/CDS/CSR/DRS/2001.2.
51. World Health Organization. Guidelines for establishing DOTS-Plus pilot projects for the management of multidrug-resistant tuberculosis (MDR-TB). Geneva; 2000. WHO/CDS/TB/2000.279.
52. World Health Organization. Guidelines for the management of drug-resistant tuberculosis. Geneva; 1997. WHO/TB/96.210.
53. Shibl A.M., Memish Z., Osoba A. Antibiotic resistance in developing countries. J. Chemother. 13:(Suppl 1):2001;40-44.
54. Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st century; 1998.
55. World Health Organization. WHO global principles for the containment of antimicrobial resistance in animals intended for food; 2000. WHO/CDS/CSR/APH/2000.4. Available from: http://www.who.int/emc/diseases/zoo/who_global_principles.html